Anesth Pain Med Search


Anesth Pain Med > Volume 10(4); 2015 > Article
Neuromuscular Physiology and Pharmacology
Anesthesia and Pain Medicine 2015;10(4):288-290.
DOI:    Published online October 31, 2015.
A suspected case of sugammadex-induced anaphylactic shock: A case report
Min Ho Hwang, Young Ju Won, Il Ok Lee, Eun Hye Koo, Woo Jun Jung
Department of Anesthesiology and Pain Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Received: 15 May 2015   • Revised: 29 July 2015   • Accepted: 30 July 2015
We describe a case involving a 69-year-old woman who developed anaphylatic shock caused by a clinical dose of sugammadex (2 mg/kg, 100 mg intravenously) 5 minutes after its administration. She developed redness and welts all over her body, and complained of an oropharyngeal itching sensation with dyspnea and dizziness. Her vital signs were closely monitored. She also experienced a sudden onset of hypotension (from 110/70 to 49/40 mmHg) and tachycardia (from 75 to 120 bpm). We diagnosed anaphylactic shock on the basis of these clinical manifestations. After 20 min of traditional treatment (hydration, ephedrine, cortisol, and phenylephrine), her vital signs returned to normal. No postoperative complications were evident, and the patient was discharged from the hospital. Although the prevalence of anaphylactic reactions to sugammadex is rare, physicians using sugammadex should be aware of the possibility of sugammadex-induced anaphylaxis.
Key Words: Anaphylactic shock, Hypersensitivity, Sugammadex

Article category

Browse all articles >


Browse all articles >

Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail:                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next